Hexagon Bio is a developer of a data-driven synthetic biotech platform that analyzes microbial genomes to develop new medicines.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/30/2022 | Series B | $67.32MM | $xx.xx | $337.51MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
15,924,145
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
09/22/2021 | Series A-Prime | $61MM | $xx.xx | $251.09MM | 8vc, Casdin Capital, Nextech Invest, Softbank, The Column Group, Two Sigma Ventures | |
Price per Share
$xx.xx
Shares Outstanding
15,421,955
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
8vc, Casdin Capital, Nextech Invest, Softbank, The Column Group, Two Sigma Ventures
|
||||||
09/16/2020 | Series A-2 | $12.96MM | $xx.xx | $92.74MM | 8vc, The Column Group, Two Sigma Ventures | |
Price per Share
$xx.xx
Shares Outstanding
7,507,829
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
8vc, The Column Group, Two Sigma Ventures
|
||||||
09/16/2020 | Series A-1 | $35MM | $xx.xx | $92.74MM | 8vc, The Column Group, Two Sigma Ventures | |
Price per Share
$xx.xx
Shares Outstanding
18,250,075
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
8vc, The Column Group, Two Sigma Ventures
|
||||||
11/01/2017 | Series Seed | $8.4MM | $xx.xx | $24MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,256,567
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|